About Annexon (ANNX)
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology... Read more
- USD2.85
- USD3.11
- USD2.74
- USD7.85
- 25.70%
- --
- 1.88M
- 1.44M
- 264M
- 1.29
- -39.70%
Stock News
3 hours ago
Dow Jones Futures: Trump Tariffs Back In Focus; Tesla Rival Uber Leads 5 Stocks In Buy Zones
Yahoo
10 hours ago
Happiness researcher shares his '90-second rule' to live a better, more fulfilled life—it helps when you're angry or upset
CNBC
10 hours ago
Retirees are flocking to these 10 U.S. states—No. 1 offers low taxes and sunny weather
CNBC
11 hours ago
Fast-casual restaurants lean on loyalty programs to offset consumer pullback
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
